Relay Therapeutics (RLAY) News Today → A lot of people are making this costly mistake (From WealthPress) (Ad) Free RLAY Stock Alerts $8.30 +0.14 (+1.72%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRelay Therapeutics (NASDAQ:RLAY) Trading Up 6.2%marketbeat.com - March 27 at 3:24 PMLeerink Partnrs Comments on Relay Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:RLAY)americanbankingnews.com - March 20 at 5:48 AMRelay Therapeutics, Inc. Forecasted to Post Q2 2024 Earnings of ($0.64) Per Share (NASDAQ:RLAY)americanbankingnews.com - March 20 at 2:54 AMStrong Buy Rating for Relay Therapeutics Amid Pipeline Progress and Strategic Directionmarkets.businessinsider.com - March 19 at 11:56 PMLeerink Partnrs Comments on Relay Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:RLAY)marketbeat.com - March 19 at 6:55 AMRLAY Apr 2024 7.500 callfinance.yahoo.com - March 16 at 2:32 AMRLAY Apr 2024 7.500 putfinance.yahoo.com - March 16 at 2:32 AM3 Precision Medicine Stocks That Could Benefit From the Industry's Riseinvestorplace.com - March 15 at 12:39 PMRelay Therapeutics (NASDAQ:RLAY) Stock Price Down 6.7%marketbeat.com - March 14 at 12:47 PMRelay Therapeutics: Platform More Important Than Programsseekingalpha.com - March 13 at 2:50 AMFmr LLC Lowers Stock Position in Relay Therapeutics, Inc. (NASDAQ:RLAY)marketbeat.com - March 6 at 4:52 AMTrexquant Investment LP Has $1.67 Million Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)marketbeat.com - March 4 at 6:30 AMRelay Therapeutics, Inc. (NASDAQ:RLAY) Shares Bought by Algert Global LLCmarketbeat.com - February 27 at 6:54 AMRelay Therapeutics to Participate in Three Upcoming Investor Conferencesglobenewswire.com - February 26 at 4:05 PMRelay Therapeutics: Strong Buy on Improved Financials and Promising Future Milestonesmarkets.businessinsider.com - February 26 at 2:36 PMRelay Therapeutics (NASDAQ: RLAY)fool.com - February 25 at 8:02 AMRelay Therapeutics Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - February 24 at 10:09 AMRelay Therapeutics (NASDAQ:RLAY) Announces Earnings Resultsmarketbeat.com - February 23 at 12:53 PMRelay Therapeutics (NASDAQ:RLAY) Sees Large Volume Increase on Better-Than-Expected Earningsmarketbeat.com - February 23 at 11:32 AMRelay Therapeutics, Inc.: Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlightsfinanznachrichten.de - February 23 at 7:55 AMOptimistic Buy Rating for Relay Therapeutics: Strong Financial Standing and Strategic Pipeline Focusmarkets.businessinsider.com - February 22 at 9:54 PMRelay Therapeutics Inc (RLAY) Reports Full Year 2023 Financial Results and Corporate Highlightsfinance.yahoo.com - February 22 at 9:54 PMRelay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlightsglobenewswire.com - February 22 at 4:05 PMRelay Therapeutics's Earnings: A Previewbenzinga.com - February 21 at 6:00 PMRelay Therapeutics Inc (RLAY)investing.com - February 21 at 12:59 PMRafferty Asset Management LLC Lowers Stake in Relay Therapeutics, Inc. (NASDAQ:RLAY)marketbeat.com - February 21 at 6:43 AMRLAY Mar 2024 7.500 putfinance.yahoo.com - February 17 at 10:36 AMRelay Therapeutics, Inc. (NASDAQ:RLAY) Stock Position Lowered by Barclays PLCmarketbeat.com - February 17 at 5:26 AMVERV Mar 2024 12.500 callfinance.yahoo.com - February 16 at 11:23 PMRelay Therapeutics (RLAY) to Release Quarterly Earnings on Thursdaymarketbeat.com - February 16 at 9:53 AMRelay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024finance.yahoo.com - February 15 at 7:53 PMRelay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024globenewswire.com - February 15 at 4:05 PMRelay Therapeutics Poised for Growth with Promising RLY-2608, Analyst Maintains Buy Ratingmarkets.businessinsider.com - February 15 at 9:47 AMRelay Therapeutics, Inc. (RLAY) Moves 10.0% Higher: Will This Strength Last?finance.yahoo.com - February 15 at 9:47 AMRelay Therapeutics, Inc. (NASDAQ:RLAY) Expected to Earn FY2027 Earnings of ($2.34) Per Sharemarketbeat.com - February 15 at 8:59 AMRelay Therapeutics: Tapping Into An Unmet Need At A High Price Tagseekingalpha.com - February 12 at 9:41 PMRelay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conferencefinance.yahoo.com - February 1 at 8:20 PMRelay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Rating of "Moderate Buy" from Analystsmarketbeat.com - January 27 at 2:53 AMTD Asset Management Inc Raises Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)marketbeat.com - January 18 at 5:31 AMRelay Therapeutics to sell 2.5M shares at $12.00 in private placementmsn.com - January 10 at 9:14 AMRelay Therapeutics Stock (NASDAQ:RLAY), Short Interest Reportbenzinga.com - January 9 at 7:59 AMRelay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 2 at 5:27 PMRelay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - January 2 at 2:37 AMHC Wainwright & Co. Maintains Buy Rating for Relay Therapeutics: Here's What You Need To Knowmarkets.businessinsider.com - December 11 at 12:41 PMRelay Therapeutics (NASDAQ:RLAY) PT Lowered to $17.00marketbeat.com - December 11 at 8:16 AMWall Street Analysts Think Relay Therapeutics, Inc. (RLAY) Could Surge 189.21%: Read This Before Placing a Betfinance.yahoo.com - November 30 at 2:54 PMUnlocking AI investment opportunities in healthcare (RLAY)marketbeat.com - November 16 at 9:00 AMWall Street Analysts See a 202.33% Upside in Relay Therapeutics, Inc. (RLAY): Can the Stock Really Move This High?finance.yahoo.com - November 14 at 1:46 PMRelay Therapeutics Stock (NASDAQ:RLAY), Analyst Ratings, Price Targets, Predictionsbenzinga.com - November 9 at 9:38 AMRelay Therapeutics to Participate in Stifel 2023 Healthcare Conferencefinance.yahoo.com - November 7 at 7:48 PM Get Relay Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLAY and its competitors with MarketBeat's FREE daily newsletter. Email Address Altcoin FRENZY Alert… (Ad)Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!) RLAY Media Mentions By Week RLAY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RLAY News Sentiment▼1.270.61▲Average Medical News Sentiment RLAY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RLAY Articles This Week▼32▲RLAY Articles Average Week Get Relay Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RLAY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RGNX News IMTX News KYTX News BCRX News CRGX News TARS News CABA News SRRK News PRME News HLVX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RLAY) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relay Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.